A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189 in Healthy Adults 18 to 30 Years of Age

NCT07478952 · clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
120
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

ModernaTX, Inc.